TickerFacts.

Neonc Technologies Holdings, Inc. (NTHI): Revenue

Annual figures by period end, from SEC filings.

$40.0K
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
$83.0K2024-12-31: $83.0K2025-12-31: $40.0K$40.0K
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$40.0K-51.8%2026-03-31, From 2025-01-01
2024-12-31$83.0Kn/a2026-03-31, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$40.0K-51.8%
Altimmune, Inc. (ALT)2025-12-31$41.0K+105.0%
Lyell Immunopharma, Inc. (LYEL)2025-12-31$36.0K-41.0%
Impact Biomedical Inc. (IBO)2025-12-31$32.0Kn/a
HCW Biologics Inc. (HCWB)2025-12-31$54.2K-97.9%
Talphera, Inc. (TLPH)2025-12-31$28.0Kn/a
Avalo Therapeutics, Inc. (AVTX)2025-12-31$59.0K-86.6%
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$64.0K-99.8%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$65.3K-70.0%

Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗